Co-Authors
This is a "connection" page, showing publications co-authored by MUHAMMAD ADRISH and NICOLA HANANIA.
Connection Strength
5.787
-
POINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? Yes. Chest. 2024 Jul; 166(1):12-17.
Score: 0.940
-
Rebuttal From Drs Adrish and Hanania. Chest. 2024 Jul; 166(1):20-21.
Score: 0.940
-
Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer? Am J Respir Crit Care Med. 2023 09 01; 208(5):509-511.
Score: 0.887
-
Asthma and cardiovascular disease: A bidirectional association? Respirology. 2023 03; 28(3):217-219.
Score: 0.853
-
Choosing and switching biological agents in severe asthma. Respirology. 2022 11; 27(11):926-928.
Score: 0.832
-
Phenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunol Allergy Clin North Am. 2022 08; 42(3):645-655.
Score: 0.818
-
Personalized COPD Care: The Future of Precision-Based Therapies. J Clin Med. 2024 Oct 23; 13(21).
Score: 0.240
-
Update on the Role of FeNO in Asthma Management. Diagnostics (Basel). 2023 Apr 15; 13(8).
Score: 0.216
-
Asthma outcomes in a safety net hospital system: A comparative study to a national cohort. Respir Med. 2025 Apr-May; 240:108032.
Score: 0.062